Piper Sandler analyst John Barnidge has maintained an Overweight rating on Corebridge Financial while raising the price target to $36 from the previous $31. The revised target indicates a positive valuation outlook for the company's stock, which trades on the NYSE under the ticker CRBG.

The decision to increase the price target alongside the Overweight stance suggests that the stock's potential upside has been reassessed favorably. The new target of $36 represents a specific adjustment to the firm's financial model for Corebridge Financial.

Rating and Price Target Details

The following table outlines the revised rating and price target details provided by Piper Sandler:

Corebridge Financial operates within the financial sector, and the analyst's report provides guidance for investors tracking the stock's performance. The maintenance of the Overweight rating implies that the stock is expected to outperform the broader market or sector averages over the near term.

Monteverde & Associates PC has launched investigations into the proposed mergers of Corebridge Financial, RE/MAX Holdings, Selectis Health, and Apogee Therapeutics to determine if the boards of these companies adequately acted in the best interests of shareholders. The law firm is examining potential breaches of fiduciary duty and other legal violations related to the transaction terms and the processes used to secure shareholder approval.

The investigations cover four distinct transactions with varying deal structures and shareholder vote deadlines. Corebridge Financial is merging with Equitable Holdings, while RE/MAX Holdings is being sold to The Real Brokerage Inc. Selectis Health is selling to Black Pearl Equities II, and Apogee Therapeutics is being acquired by AbbVie Inc. The firm is reviewing whether the consideration offered to shareholders is fair and if all material information was disclosed prior to the votes.

Transaction Details and Deadlines

The following table summarizes the key details of the mergers under investigation, including the proposed consideration and critical dates for shareholders.

Shareholder Actions

Monteverde & Associates PC advises shareholders who own stock in these companies to contact the firm to discuss their rights and potential legal remedies. The firm emphasizes that there is no cost or obligation for the consultation. Shareholders must act promptly given the approaching deadlines for votes and tender offers.

Juan Monteverde, the lead attorney at Monteverde & Associates PC, stated that the firm is focused on recovering losses for shareholders and ensuring that corporate boards adhere to their fiduciary duties during merger negotiations. The firm is headquartered at the Empire State Building in New York City and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.